These findings suggested that the SIRT1‐CX3CL1 axis was critical in promoting the progression and spread of CRC and could serve as a prognostic biomarker for identifying patients with a high likelihood of poor outcomes. This evidence concerns the gene SIRT1 and colorectal carcinoma.